Trials / Recruiting
RecruitingNCT07054879
CtDNA-guided Maintenance Therapy in Pancreatic Cancer
A Prospective Single-center Observational Study: ctDNA-guided Maintenance Therapy for Postoperative Pancreatic Cancer
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (estimated)
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to conduct a large-scale prospective clinical trial to evaluate the efficacy and safety of capecitabine monotherapy as maintenance treatment following standard adjuvant chemotherapy (gemcitabine plus capecitabine) in patients with resectable pancreatic cancer, and to analyze whether ctDNA-MRD testing can guide the selection of postoperative maintenance therapy.
Conditions
Timeline
- Start date
- 2024-11-01
- Primary completion
- 2025-12-31
- Completion
- 2027-01-01
- First posted
- 2025-07-08
- Last updated
- 2025-07-08
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07054879. Inclusion in this directory is not an endorsement.